NewSpring

NewSpring Capital, founded in 1999 and based in Radnor, Pennsylvania, is a private equity firm that focuses on equity and debt investments across the United States. The firm manages over $2 billion and employs multiple investment strategies, including growth equity, control buyouts, and mezzanine debt. NewSpring invests in innovative franchise and multi-unit concepts, primarily targeting dynamic industries such as technology, communication, and business services. With a history of investing in over 150 companies, NewSpring partners with management teams to foster growth and develop businesses into market leaders. The firm emphasizes building relationships within its extensive network of industry leaders to identify and capitalize on compelling investment opportunities.

Kamal Advani

Operating Partner

James Ashton

General Partner

Caio Azevedo

Associate

Gregory Barger

General Partner

Hart Callahan

Partner

Jacques Clariond

Analyst

Kirk Clark

Vice President

Andrew DeBacco

Senior Associate

Joe Deluca

Operating Partner

Michael DiPiano

Managing Director

Matt DiTosto

Associate

Bruce Downey

Partner

Jason Dresner

Senior Associate

Lee Garber

Partner

Matt Giangiordano

Senior Associate

Joseph A. Hawke

Partner

Jonathan Hsu

Investor

Mike Kaplan

Partner

Brian Kelly

Senior Associate

Brian Kim

Growth Equity Investor and Partner

Kristin Lee

Partner, Mezzanine Strategy

Matthew Malinowski

Senior Associate

Skip Maner

General Partner

Nathan Myers

Principal

Justin Nadile

Principal

Andrew Panzo

General Partner

Matthew Plevelich

Principal

Satya Ponnuru

General Partner

Kapila Ratnam

Partner

Glenn Rieger

General Partner

Brian Ruwe

Vice President

Daniel Salvato

Principal

Tarun Sangari

Senior Associate

Bharat Santhanam

Principal

Drew Scannell

Principal

Jonathan Schwartz

President and COO

David Siegel

Associate

Patrick Sugrue

General Partner

Matt Szymanski

Senior Associate

Robert Valvano

Principal

Bob Valvano

Principal

Anne Vazquez

General Partner

Amy Wang

Vice President

Sean Whitehead

Senior Associate

Joseph Willamson

Partner

Past deals in Maryland

Circonus

Series B in 2021
Circonus, Inc. is a machine data intelligence platform that specializes in real-time handling of IoT and IT infrastructure data. Founded in 2010 and headquartered in Fulton, Maryland, the company provides solutions that allow organizations to collect, store, manage, and analyze vast streams of data. Circonus enables users to visualize and monitor their data in real time, facilitating the identification and resolution of IT infrastructure issues. Its platform supports various functionalities, including predictive analytics, trend monitoring, and operational insights, making it suitable for applications in infrastructure monitoring, IoT, cloud monitoring, and DevOps. Circonus serves diverse industries such as advertising technology, entertainment, financial technology, logistics, and smart utilities, helping them optimize operations and enhance user experiences through accurate and timely data.

Circonus

Series A in 2020
Circonus, Inc. is a machine data intelligence platform that specializes in real-time handling of IoT and IT infrastructure data. Founded in 2010 and headquartered in Fulton, Maryland, the company provides solutions that allow organizations to collect, store, manage, and analyze vast streams of data. Circonus enables users to visualize and monitor their data in real time, facilitating the identification and resolution of IT infrastructure issues. Its platform supports various functionalities, including predictive analytics, trend monitoring, and operational insights, making it suitable for applications in infrastructure monitoring, IoT, cloud monitoring, and DevOps. Circonus serves diverse industries such as advertising technology, entertainment, financial technology, logistics, and smart utilities, helping them optimize operations and enhance user experiences through accurate and timely data.

Circonus

Series A in 2016
Circonus, Inc. is a machine data intelligence platform that specializes in real-time handling of IoT and IT infrastructure data. Founded in 2010 and headquartered in Fulton, Maryland, the company provides solutions that allow organizations to collect, store, manage, and analyze vast streams of data. Circonus enables users to visualize and monitor their data in real time, facilitating the identification and resolution of IT infrastructure issues. Its platform supports various functionalities, including predictive analytics, trend monitoring, and operational insights, making it suitable for applications in infrastructure monitoring, IoT, cloud monitoring, and DevOps. Circonus serves diverse industries such as advertising technology, entertainment, financial technology, logistics, and smart utilities, helping them optimize operations and enhance user experiences through accurate and timely data.

USPack

Private Equity Round in 2015
Founded in 1986 by Peter Glazman, USPack Logistics has grown steadily into the premier name in New York courier services. Since our inception they’ve held true to the simple ideal that they were founded upon: keep it personal. Over the past two decades they’ve never wavered in our dedication to personalized service standards. Still at the helm today, Mr. Glazman has pursued a strategy of measured growth through calculated acquisitions and careful investment decisions. Today they provide a wide array of same day and daily routed delivery services to New York, New Jersey, Connecticut, Washington D.C., Maryland, Virginia, Pennsylvania and beyond. Our couriers specialize in getting packages through the hustle of busy streets quickly, safely, and affordably.

Message Systems

Debt Financing in 2015
Message Systems is a computer software company providing email infrastructure, authentication, security, and marketing services.

Paragon Bioservices

Series A in 2014
Paragon Bioservices, Inc. is a contract development and manufacturing organization (CDMO) based in Baltimore, Maryland, specializing in the development and production of biopharmaceuticals. The company focuses on advanced biotechnologies, including viral vector-based gene therapies, next-generation vaccines, monoclonal antibodies, and recombinant proteins. Paragon offers comprehensive services that encompass process development, analytical development, and cGMP manufacturing for pre-clinical and Phase I/II clinical activities. Its customer base has shifted predominantly to commercial engagements within the biotech sector, moving away from substantial government contracts. Paragon has strengthened its leadership team with seasoned professionals who possess extensive industry experience, reinforcing its commitment to delivering high-quality manufacturing services. The company operates from a state-of-the-art 150,000 square foot facility, providing a full spectrum of manufacturing capabilities from initial process development through to commercial launch. As a subsidiary of Catalent, Inc., Paragon Bioservices is positioned to be a key player in the evolving biopharmaceutical landscape.

Atlantic Diagnostic Laboratories

Debt Financing in 2012
Atlantic Diagnostic Laboratories is a clinical laboratory that offers a comprehensive range of testing services, including microbiology, chemistry, toxicology, immunology, and virology. The laboratory serves clients across multiple states, including Pennsylvania, New Jersey, New York, Delaware, Maryland, Connecticut, Virginia, Florida, Ohio, Kentucky, and West Virginia. With over thirty years of experience, Atlantic Diagnostic Laboratories caters to a diverse clientele, such as physicians' offices, pain management clinics, drug rehabilitation centers, nursing homes, and hospitals. The facility spans 26,000 square feet and is equipped to provide personalized and efficient laboratory services. The company is particularly known for its high-end toxicology tests, which are essential for evaluating drug overdoses, both accidental and intentional, making it a valuable partner in the healthcare industry.

Aisthesis

Private Equity Round in 2012
Aisthesis is an anesthesia management company that specializes in delivering custom anesthesia care solutions. The company was founded in 1991 and is headquartered in Bethesda, Maryland, United States.

Corridor Pharmaceuticals

Series A in 2010
Corridor Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutic small molecule inhibitors of arginase. Its arginase is an enzyme that competes with endothelial nitric oxide synthase for the use of the common substrate l-arginine. The company's arginase also leads to the production of ornithine which increases polyamine, stimulating cell division, and contributing to hyperplasia and fibrosis. Corridor Pharmaceuticals, Inc. was formerly known as Arginetix, Inc. and changed its name to Corridor Pharmaceuticals, Inc. on June 17, 2010. The company was founded in 2007 and is based in Lutherville, Maryland.

The Matworks Company

Private Equity Round in 2006
The Matworks Company is a building materials firm specializing in the manufacturing and retail of matting and flooring products. The company offers a wide range of solutions, including entrance flooring, wall-to-wall flooring, and anti-fatigue mats. Additionally, it provides cleaning and maintenance services tailored for big-box retailers across the United States and Canada. Through its comprehensive offerings, The Matworks Company aims to meet the diverse flooring needs of its clients while ensuring quality service and installation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.